SHE MD Understanding Melanoma: Breakthroughs, Risk Factors, and Prevention with Dr. Omid Hamid
In this episode of SHE MD, Dr. Thaïs Aliabadi and Mary Alice Haney welcome melanoma specialist Dr. Omid Hamid. They explore the rising incidence of melanoma in young people, debunk common misconceptions, and discuss groundbreaking treatments. Dr. Hamid explains the different stages of melanoma and the revolutionary immunotherapy treatments that are changing patient outcomes. The hosts and guest discuss real-life cases, including those of celebrities Khloe Kardashian and Teddy Mellencamp, to illustrate the importance of awareness and regular skin checks. The conversation also touches on melanoma during pregnancy and genetic predisposition to the disease - learn why genetic testing is crucial, even without family history.
Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii.
Sponsors:
Myriad: Knowing your family's history of cancer is the first step to understanding your own cancer risk and may qualify you for the MyRisk Hereditary Cancer Test with RiskScore hereditary cancer test. It's easy, accurate and covered by most insurers.
Learn more at GetMyRisk.com
Cymbiotika: Go to Cymbiotikia.com/SHEMD for 20% off your order
+ free shipping today.
Purely Elizabeth: Visit purelyelizabeth.com and use code SHEMD at checkout for 20% off. Purely Elizabeth. Taste the Obsession
Equip: To learn more about Equip treatment, visit equip.health/sobermomlife.
Strivektin: Discover the Science Behind Great Skin
David’s Protein: David is giving my listeners an exclusive offer – buy four cartons and get the fifth free at davidprotein.com/shemd
Cure Hydration: Cure is offering 20% off your first order! Stay hydrated and feel your best by visiting curehydration.com/SHEMD and using promo code SHEMD at checkout.
Dr. Omid Hamid’s Key Takeaways:
1. Reduce Sun Exposure: Limit time spent in direct sunlight, especially during peak hours. Use protective clothing, hats, and sunglasses to shield your skin from harmful UV rays.
2. Schedule Regular Skin Checks: Schedule routine visits with a dermatologist for comprehensive skin examinations. Self-examine your skin monthly for any new or changing moles or lesions.
3. Use Effective Sunscreen: Apply broad-spectrum sunscreen with at least SPF 30 daily, even on cloudy days. Reapply every two hours when outdoors, and after swimming or sweating.
4. Get Genetic Testing Done: If you have a family history of melanoma or other cancers, consider genetic testing to assess your risk. Tests like the MYRIS can identify melanoma-related gene mutations.
5. Avoid Tanning Beds: Steer clear of tanning beds, as they significantly increase the risk of developing melanoma and other skin cancers.
6. Be Your Own Health Advocate: Stay informed about your health, ask questions, and seek second opinions if necessary. Advocate for yourself and your loved ones by being proactive about potential health concerns.
In This Episode:
(00:00) Intro: Melanoma Awareness Month
(02:40) Dr. Omid Hamid: Melanoma specialist introduction
(6:58) Surgery for melanoma explained
(10:49) Immunotherapy revolutionizes melanoma treatment
(14:57) Genetic testing for melanoma risk
(23:25) Importance of advocating for yourself
(32:22) Teddy Mellencamp's stage 4 melanoma journey
(50:51) Hormonal changes and melanoma risk
(57:00) Two key melanoma prevention tips
RESOURCES:
Melanoma Research Alliance: https://www.curemelanoma.org/blog/omid-hamid-md
Melanoma Research Foundation https://melanoma.org/
Myriad Genetics: https://myriad.com/
GUEST BIOGRAPHY:
Omid Hamid, MD, is the Chief of the Translational Research and Immuno-Oncology Department at The Angeles Clinic and Research Institute and serves as the Co-Director of the Melanoma and Phase I Programs. Academic Title as Professor, Department of Medicine at Cedars-Sinai Medical Center. His areas of expertise include immunotherapy and Phase I drug development.
Dr. Hamid has published extensively and has been at the forefront of the development of paradigm-shifting breakthroughs including BRAF/MEK targeted agents, AntiCTL4A, antiPD1, and PDL1 therapies. His current interests include new immunotherapeutic options for patients including bi-specific antibodies, Adoptive T-cell Therapy, and oncolytic therapies with a focus on combinatorial approaches resulting in potentially great patient benefit.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.